Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Noncurrent inventories by Quarter
Noncurrent inventories (included in Other noncurrent assets) ($M) ($M)
Pfizer Noncurrent inventories: $2,419M in Q2 2026, up 2.5% from a year earlier.
Latest, Q2 2026
2,419
Period ended Jun 28, 2026
Change on a year earlier
+2.5%
2,360 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
45
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Inventories Footnote.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Noncurrent inventories (included in Other noncurrent assets) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 2,419 | +2.5% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 2,462 | -11.9% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,370 | -11.0% | Form 10-Q (filed 2026-08-04) ↗ |
| Q3 2025 | Sep 28, 2025 | 2,142 | -22.5% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 2,360 | -19.1% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 2,793 | -16.9% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,663 | -41.7% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 2,765 | +95.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,918 | -50.3% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,361 | -40.2% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 4,568 | -21.6% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 1,416 | -57.4% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 5,868 | +522.3% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 5,616 | +528.2% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 5,827 | +520.6% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2022 | Oct 2, 2022 | 3,327 | +255.8% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 943 | -3.9% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 894 | -8.9% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 939 | +5.5% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2021 | Oct 3, 2021 | 935 | -1.4% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2021 | Jul 4, 2021 | 981 | +2.0% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2021 | Apr 4, 2021 | 981 | +36.3% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2020 | Dec 31, 2020 | 890 | +39.5% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2020 | Sep 27, 2020 | 948 | +40.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | 962 | +48.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | 720 | +13.0% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | 638 | +3.2% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2019 | Sep 29, 2019 | 677 | +17.5% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 646 | +5.0% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 637 | -0.5% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 618 | -9.5% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 576 | -13.9% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 615 | -18.4% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 640 | -3.8% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 683 | 0.0% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2017 | Oct 1, 2017 | 669 | +14.8% | SEC Filing ↗ |
| Q2 2017 | Jul 2, 2017 | 754 | +26.9% | SEC Filing ↗ |
| Q1 2017 | Apr 2, 2017 | 665 | +3.3% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 683 | +15.0% | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2016 | Oct 2, 2016 | 583 | +8.2% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 594 | +24.3% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 644 | +37.9% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 594 | – | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2015 | Sep 27, 2015 | 539 | – | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 478 | – | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 467 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Pfizer Noncurrent inventories ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/inv-noncur
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.